29 October 2024 Sean Mosby 2057 Case Updates Pfizer Inc v Uniqure Biopharma BV [2024] EWHC 2672 (Pat) bySean Mosby Summary The judge in this patent case found that the claimants’ gene therapy expert had developed, quite possibly guided by lawyers, the understanding that the primary duty of an expert witness is not to say anything that may damage the instructing party’s case if it can be avoided. To continue reading you must be an EWI member, become a member and access exclusive content. Already a member? Login More links Link to the Judgment Share Print Tags 16. Criticism and Complaints06. Rules and Regulations11. Report Writing08. Working with Instructing Parties15. Giving Oral Evidence Related articles Podcast Episode 23: Experts in the Courts What were the effects of repeated sexual abuse at the hands of a schoolteacher? An expert report that is almost worse than useless When experts are the subject of regulatory complaints If you're wearing two hats, make sure you comply with the rules Comments are only visible to subscribers.